Skip to main content
The Oncofertility Consortium

The Oncofertility Consortium

Search Open menu

Search form

Onco_Main_Menu

  • About
    • Find out more about the Oncofertility Consortium

      More
      Dr. Teresa K. Woodruff
      Oncofertility Consortium Vision 2030
      Oncofertility Professional Engagement Network
      Scientific Committees
      Contact Us
  • Resource Browser
    • Explore resources for patients, physicians and educators

      More
      For Patients
      For Health Care Professionals
      For Researchers
      For Educators
      For OPEN Members and Global Partners
  • News
    • The latest from the Oncofertility Consortium

      More
      Newsletter
      Events
      Stories
      Blog
      Give Now
  • Find a Clinic / Center
  • Dialogues
    • Explore Dialogues in Oncofertility

      More
      Dialogues
      Webinars
      Videos
      Books
      Publications
      Surveys

You are here

  1. Home
  2. » Blog
  3. » 2011

Blog Archive: January 2011

List
Visual

Ovaries: Organs or gametes?

January 31, 2011
pkt551

Female cancer patients interested in preserving their fertility prior to treatment may choose from a variety of options including egg banking, embryo banking, or ovarian tissue cryopreservation. While some fertility preservation techniques, such as egg and embryo baking, require a 2 to 3 week delay in cancer treatment, ovarian removal and cryopreservation allow women to proceed with cancer treatment almost immediately. After the survivor is cancer-free and wants to have a child, pieces of her ovary can be transplanted back into her body to begin releasing eggs that are unaffected by chemotherapy and radiation. Most cases of ovarian tissue transplantation are called autografts since the donor and recipient are the same. In a few rare cases, women have received ovarian tissue from other individuals, usually sisters.

These rare cases raise an interesting question to ethicists at the Oncofertility Consortium; should ovarian transplantation between two women be legally treated like organs or gametes? The US government regulates organs listed under the National Organ Transplantation Act and sale of these organs is prohibited. In contrast, gametes, such as eggs and sperm, are unregulated and legally able to be purchased and sold. While ovaries are definitely organs, they also hold genetic material with the potential to become life. Oncofertility ethicist Lisa Campo-Engelstein, PhD, discusses these issues in a recent publication titled “Gametes or Organs? How Should we Legally Classify Ovaries Used for Transplantation in the USA?”

The article, published in the Journal of Medical Ethics, discusses that the intended use of the ovary should play a major part in categorizing the donation. One 30-year-old woman identified in the article lost her fertility after cancer treatment for non-Hodgkins lymphoma. Her sister donated an ovary to her so she could carry and give birth to a child. In contrast, another patient requested autotransplantation of her own ovarian tissue not to have a child but to relieve early onset menopausal symptoms. While these two intended uses of ovarian tissue are quite different, they may play roles in the legal, ethical, and insurance designations of such transplants.

In the article, Dr. Campo-Engelstein suggests that ovarian tissue should be classified as a gamete because, in either case, once ovarian tissue is donated to a recipient, it may be used to produce offspring, even if that was not the original intent. It is important to remember that these cases are quite rare and it is unlikely that ovarian tissue donation will become common. However, the Oncofertility Consortium believes it is necessary to include ethical scholars into the discussion of any emerging technology as their insights can help guide the scientific research.

Categories: 

  • Fertility Preservation, General, Research

Tags: 

  • ethics, ovarian tissue cryopreservation, Personal stories

Pregnant with Cancer

January 28, 2011
pkt551

Emerging Treatments and Education for Blood Cancers

January 25, 2011
pkt551

Premature Menopause: The Unexpected Symptoms of Cancer Treatment

January 24, 2011
pkt551

New Publication: Oncofertility and Gender Roles

January 17, 2011
pkt551

ASCO University for Cancer Providers

January 13, 2011
pkt551

National Cancer Institute Committed to Oncofertility

January 12, 2011
pkt551

Obesity, Oncology, and Oncofertility

January 7, 2011
pkt551

Testing Female Fertility After Cancer

January 6, 2011
pkt551

Fertility Options AFTER Cancer

January 3, 2011
pkt551

Subscribe for Email Updates

Categories

  • Advocate (73)
  • Cancer (206)
  • Children (32)
  • Cme (5)
  • Communication (16)
  • Conferences (146)
  • Education (90)
  • Ethics (27)
  • Fertility (119)
  • Fertility Preservation (335)
  • General (353)
  • Global Partner (69)
  • In The News (136)
  • Introductions (46)
  • Meetings (78)
  • National Physicians Cooperative (40)
  • Oncofertility (354)
  • Oncofertility Saturday Academy (27)
  • Patient Stories (28)
  • Publication (27)
  • Research (176)
  • Science (44)
  • Virtual Grand Rounds (20)

Blog

  • June 2019 (1)
  • May 2019 (1)
  • April 2019 (1)
  • March 2019 (1)
  • October 2018 (11)
  • September 2018 (5)
  • August 2018 (3)
  • June 2018 (2)
  • May 2018 (1)
  • April 2018 (4)
  • March 2018 (1)
  • February 2018 (6)
  • January 2018 (5)
  • December 2017 (3)
  • November 2017 (2)
  • October 2017 (3)
  • September 2017 (1)
  • August 2017 (1)
  • July 2017 (8)
  • June 2017 (8)
  • May 2017 (5)
  • April 2017 (1)
  • March 2017 (5)
  • February 2017 (6)
  • January 2017 (6)
  • December 2016 (6)
  • November 2016 (5)
  • October 2016 (2)
  • September 2016 (2)
  • July 2016 (5)
  • June 2016 (10)
  • May 2016 (8)
  • April 2016 (14)
  • March 2016 (14)
  • February 2016 (14)
  • January 2016 (2)
  • November 2015 (27)
  • October 2015 (15)
  • September 2015 (5)
  • August 2015 (2)
  • July 2015 (2)
  • June 2015 (1)
  • May 2015 (3)
  • April 2015 (5)
  • March 2015 (3)
  • February 2015 (5)
  • January 2015 (2)
  • December 2014 (1)
  • November 2014 (2)
  • October 2014 (3)
  • September 2014 (2)
  • August 2014 (4)
  • July 2014 (4)
  • June 2014 (6)
  • May 2014 (8)
  • April 2014 (4)
  • March 2014 (5)
  • February 2014 (7)
  • January 2014 (3)
  • December 2013 (3)
  • November 2013 (5)
  • October 2013 (7)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (4)
  • June 2013 (8)
  • May 2013 (7)
  • April 2013 (7)
  • March 2013 (4)
  • February 2013 (6)
  • January 2013 (4)
  • December 2012 (5)
  • November 2012 (5)
  • October 2012 (11)
  • September 2012 (10)
  • August 2012 (13)
  • July 2012 (8)
  • June 2012 (9)
  • May 2012 (11)
  • April 2012 (10)
  • March 2012 (16)
  • February 2012 (10)
  • January 2012 (13)
  • December 2011 (9)
  • November 2011 (9)
  • October 2011 (11)
  • September 2011 (7)
  • August 2011 (12)
  • July 2011 (10)
  • June 2011 (10)
  • May 2011 (9)
  • April 2011 (9)
  • March 2011 (12)
  • February 2011 (10)
  • January 2011 (10)
  • December 2010 (8)
  • November 2010 (11)
  • October 2010 (13)
  • September 2010 (6)
  • August 2010 (14)
  • July 2010 (15)
  • June 2010 (9)
  • May 2010 (6)
  • April 2010 (4)
  • March 2010 (3)
  • February 2010 (2)
  • January 2010 (7)
  • December 2009 (1)
  • November 2009 (10)
  • October 2009 (8)
  • September 2009 (7)
  • August 2009 (7)
  • July 2009 (27)
  • June 2009 (14)
  • May 2009 (13)
  • April 2009 (3)
  • March 2009 (4)
  • February 2009 (7)

Disclaimer

The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Oncofertility Consortium

 

Michigan State University

Department of Obstetrics, Gynecology and Reproductive Biology

965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 6434
Email: oncofert@msu.edu

NOTICE:

Ownership of this website has been transferred from Northwestern University to Michigan State University.
Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.

Social Media

  • Contact Information |
  • Site Map |
  • Privacy Statement |
  • Site Accessibility
  • Call MSU: 1 (517) 884-6434 |
  • Visit: msu.edu |
  • MSU is an affirmative-action, equal-opportunity employer. |
  • Notice of Nondiscrimination
  • SPARTANS WILL. |
  • © Michigan State University